Welcome!
Welcome to Aclepsa Discount Generic Pharmacy, your one-stop destination for affordable high-quality medications.
We carry a very large selection of generic medications. We stock generic equivalents of US FDA approved prescription drugs through our fully-licensed overseas pharmacy.
Why order from Aclepsa:
- Save up to 70% off retail prices by ordering online
- Everyday low medication prices
- On-line real-time order tracking from our pharmacy to your doorstep
- Strict medication quality standards
- Over 1100 different drug products in stock
- 24x7 customer support
- Order as many products as you like and never pay a shipping fee.
We have one function and one function only, to save you money on your medication.
We provide top-quality products, world-class customer service, excellent value for money, and we welcome your feedback.
Try us - you will not be disappointed!
Full Drug List
List Drugs by First Letter
Click on a letter to get a list of drug names starting with that letter:
List Drugs by Name
Enter all or part of the name of the drug you are looking for:
Contact Us
By phone, live chat, e-mail, or callback request with questions about drug availability.
New! Call our expanded customer support center toll-free at
1-866-978-4944,
7 AM - 9 PM EST Mon - Fri, 9 AM - 5 PM EST Sat - Sun.
Free Shipping!
Shipping is free regardless of destination. There are no dispensing fees, membership fees, or any other hidden fees. Orders are sent by Registered Air Mail. Delivery time to the USA is typically 10 business days after we have sent the order, though it can take longer.
FDA Drug News
MedWatch Safety Alert RSS Feed
FDA MedWatch Safety Alerts
http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/MedWatch/rss.xml
en-us
Thu, 09 Sep 2010 16:50:00 -0400
jay.wattenberg@fda.hhs.gov (Jay Wattenberg)
FDA MedWatch
http://www.fda.gov/ucm/groups/fdagov-public/documents/image/ucm052224.gif
http://www.fda.gov/Safety/MedWatch/default.htm
144
52
FDA MedWatch Safety Alerts
Gadolinium-based Contrast Agents: Class Labeling Change - Risk of Nephrogenic Systemic Fibrosis
New recommendations in labeling for screening for renal disease prior to use and monitoring for the development of NSF.
Thu, 09 Sep 2010 16:50:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm225375.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm225375.htm
AngioSculpt "EX" PTCA Scoring Balloon Catheter by AngioScore, Inc.: Recall - Risk of Catheter Separation
Fragments of the catheter may become lodged in coronary arteries, resulting in serious injury or death.
Wed, 08 Sep 2010 13:50:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm225186.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm225186.htm
Tygacil (tigecycline): Label Change - Increased Mortality Risk
Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
Wed, 01 Sep 2010 10:00:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224626.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224626.htm
Huber Needles: Recall - Risk of Coring
Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling t